Cutaneous Leishmaniasis Clinical Trials

52 clinical trials for Cutaneous Leishmaniasis across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Feasibility of Integrating Thermotherapy for Treatment of Cutaneous Leishmaniasis in Primary Health Care Setup — RECRUITING · NA
• Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate — RECRUITING · PHASE2
• Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis — RECRUITING · PHASE2
• Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis — RECRUITING · PHASE2
• Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers — NOT_YET_RECRUITING · NA
• Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis — NOT_YET_RECRUITING · PHASE1
• Epidemiology of Cutaneous Leishmaniasis in Niger, Mali, Togo : Mapping of Clinical Cases, Species, Reservoirs and Vectors of the Disease — COMPLETED
• Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in Ethiopia — COMPLETED
• Intralesional Antimony for Bolivian Cutaneous Leishmaniasis — COMPLETED · PHASE2
• Miltefosine to Treat Mucocutaneous Leishmaniasis — COMPLETED · PHASE2
• Performance of RPA-LF for Cutaneous Leishmaniasis — COMPLETED
• Efficacy of Intra-lesional Injections of Glucantime Once a Week or Twice a Week in the Treatment of Anthroponotic Cutaneous Leishmaniasis (ACL) — COMPLETED · PHASE3
• Miltefosine and GM-CSF in Cutaneous Leishmaniasis — COMPLETED · PHASE3
• Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis — COMPLETED · PHASE2
• Surveillance for Leishmaniasis Skin Lesions in Mali — COMPLETED
• Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨ — COMPLETED · PHASE2
• Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396 — TERMINATED · PHASE2
• Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia. — COMPLETED · PHASE3
• Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis — COMPLETED · PHASE2
• Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama — COMPLETED · PHASE3
• Accuracy of a Rapid Diagnostic Test for Cutaneous Leishmaniasis in Morocco — COMPLETED
• Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World — COMPLETED · PHASE2
• Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis — COMPLETED · PHASE2
• WR 279,396 for the Treatment of Cutaneous Leishmaniasis — COMPLETED · PHASE2
• Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis — COMPLETED · PHASE2
• Pharmacokinetics of Miltefosine in Children and Adults — COMPLETED · PHASE4
• Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia — COMPLETED · PHASE1
• Cosmetic Outcome of Leishmaniasis Scar After WR279396 Application — COMPLETED · NA
• High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus — TERMINATED · PHASE3
• WR 279,396 Open Label Treatment Protocol in Tunisia — TERMINATED · PHASE2
• Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients — OTHER
• Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis — TERMINATED · PHASE2
• Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia) — COMPLETED · PHASE3
• A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis — COMPLETED · PHASE2
• Safety, False-Positive Reactions and Sensitizing Properties of Leishmania Tropica Skin Test Antigen — COMPLETED · PHASE2
• Efficacy of Radio-frequency Induced Heat (RFH)Therapy in Treatment of Cutaneous Leishmaniasis in India — COMPLETED · PHASE4
• Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis — COMPLETED · PHASE1
• Efficacy Trial on Oral Miltefosine in Comparison With Glucantime in the Treatment of ACL Caused by L. Tropica — COMPLETED · PHASE3
• Study of the Efficacy of Daylight Activated Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis — OTHER · PHASE2
• Frequency of Parasite Infection in Hyraxes and Sandflies During Outbreak of Leishmania Tropica Epidemic in The West Bank — OTHER
• Oral Miltefosine Plus Topical Imiquimod to Treat Cutaneous Leishmaniasis — COMPLETED · PHASE2
• Treatment of Cutaneous Leishmaniasis With a Combination of Miltefosine and Antimony — TERMINATED · PHASE2
• Pilot Study Using a Heat Pack to Treat Cutaneous Leishmaniasis — OTHER
• Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis — TERMINATED · PHASE3
• Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia — COMPLETED · PHASE2
• Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia — OTHER · PHASE3
• Reduced Doses of Antimony Plus Ranulocyte Monocyte Colony Stimulating Factor (GM-CSF) for Cutaneous Leishmaniasis — COMPLETED · PHASE2
• Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis — COMPLETED · PHASE4
• Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis — COMPLETED · PHASE3
• Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants — COMPLETED · PHASE1

Refine this search